Company news
Telesta Therapeutics Inc news in 2015
Telesta Therapeutics Inc's news releases, calls and decks from 2015, newest first.
Telesta Therapeutics Corporate Update
December 14, 2015
Telesta Therapeutics Announces Results of the FDA Advisory Committee Vote
November 19, 2015
Telesta Therapeutics Inc. Announces Results of Annual General Meeting of Shareholders
November 16, 2015
Telesta Therapeutics Publishes its Q1, 2016 Financial Statements and Provides Corporate Updates
November 12, 2015
Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories
October 28, 2015
Telesta Therapeutics Appoints Brian J. Groch as Chief Commercial Officer
October 8, 2015
Telesta Announces FDA Advisory Committee Date for MCNA1
September 28, 2015
Telesta Therapeutics Publishes its Annual Consolidated Financial Statements and Provides Corporate Updates
September 14, 2015
Telesta Receives FDA BLA Filing Notification Letter and Priority Review Designation for MCNA(1)
August 28, 2015
Telesta Therapeutics Closes US$28.6 Million Private Placement
August 19, 2015
Telesta Therapeutics Announces South Korean Partnership for MCNA & Concurrent Private Placement
July 20, 2015
Telesta Therapeutics Submits Biologics License Application (BLA) to the U.S. FDA
June 30, 2015
Telesta Therapeutics Announces Issuance of Key U.S. MCNA Composition of Matter Patent
June 3, 2015
Telesta Therapeutics Publishes its Nine Month Financial Results to March 31, 2015 and Provides Corporate Updates
May 14, 2015
Telesta Therapeutics Provides Key Corporate Updates
April 27, 2015
Telesta Therapeutics Publishes its 6 Month Financial Results to December 31, 2014 and Provides Important Corporate Updates
February 13, 2015